<p>南卡羅來納州北查爾斯頓 --（商業資訊）--Ingevity Corporation（紐約證券交易所代碼：NGVT）今天宣佈了關鍵的高管領導變動，以完成其戰略投資組合審查併為公司的未來做好準備。</p>
<p><strong>首席財務官過渡</strong></p>
<p>Mary Dean Hall，執行副總裁兼首席財務官（CFO），將於 2026 年 5 月 1 日起從當前職位過渡，並在接下來的一年內繼續以顧問身份支持公司。自 2021 年以來，Hall 一直擔任 CFO，在加強 Ingevity 的財務基礎、提升運營紀律和支持戰略增長計劃方面發揮了關鍵作用。在她的財務領導下，公司實現了顯著的利潤率擴張，改善了資本結構，並交出了強勁的自由現金流表現。</p>
<p>“Mary 一直是我們財務戰略的可信顧問和推動力，” 首席執行官 Dave Li 表示。“她深厚的專業知識和穩定的指導對 Ingevity 的長期成功至關重要。我們感謝她的領導，並很高興她在這一過渡期間繼續支持公司。”</p>
<p>公司已任命 Phillip J. Platt，現任高級副總裁、財務和首席會計官，作為 Hall 的繼任者，併成為執行領導團隊的一員，任職將於 2026 年 5 月 1 日生效。自 2015 年加入 Ingevity 以來，Platt 擔任過多個關鍵財務領導職務，領導財務報告的改進，推動業務流程轉型，並主導公司全球企業資源規劃（ERP）系統的實施。他在全球財務運營的監督和推動技術驅動的流程改進方面的經驗，使他能夠很好地指導 Ingevity 的財務戰略並支持公司的長期增長。</p>
<p><strong>性能化學品業務總裁過渡</strong></p>
<p>Rich White，高級副總裁兼性能化學品總裁，將於 2026 年 1 月 1 日起過渡到特別項目角色，並於 2026 年 5 月 1 日離開公司。White 於 2021 年被任命為性能化學品部門的總裁，自那時以來，他領導性能化學品經歷了戰略重組的階段，包括利潤率改善計劃、產品組合優化和運營精簡。</p>
<p>“我們感謝 Rich 對 Ingevity 的領導和貢獻，” Li 表示。“在過去的幾年中，他引導業務應對複雜的市場環境，並領導努力重組部門投資組合，以符合我們的戰略優先事項。在他從當前角色過渡時，我們對他的指導表示感激，並相信他的專業知識將有助於確保連續性和穩定性。”</p>
<p><strong>新任高級副總裁的任命</strong></p>
<p>Ingevity 還宣佈任命 Reid Clontz 為高級副總裁、運營及 Ingevity 執行領導團隊成員，任職將於 2025 年 12 月 8 日生效。Clontz 最近擔任 Ingevity 的全球運營副總裁，擁有超過二十年的化工行業經驗，領導多個製造基地的運營，提高流程效率，並將生產與可持續發展目標對齊。他的領導在優化工廠運營和推動公司全球各地的持續改進方面發揮了重要作用。在新角色中，Clontz 還將負責公司的供應鏈、採購和安全職能。</p>
<p>“這些領導層的變動反映了我們致力於發展組織以支持長期戰略優先事項，” Li 表示。“我們感謝 Mary 和 Rich 的重大貢獻，並對 Reid 和 Phil 的新角色表示歡迎，確信他們深厚的運營和戰略專業知識將幫助 Ingevity 繼續實現增長和成功。”</p>
<p><strong>Ingevity：淨化、保護、提升</strong></p>
<p>Ingevity 提供淨化、保護和提升我們周圍世界的產品和技術。通過一支才華橫溢且經驗豐富的團隊，我們開發、製造並推向市場的解決方案，幫助客户解決複雜問題，使世界更加可持續。我們在三個報告部門運營：性能材料，包括活性炭；先進聚合物技術，包括己內酰胺聚合物；以及性能化學品，包括特種化學品和鋪路技術。我們的產品用於多種苛刻應用，包括粘合劑、農用化學品、瀝青鋪路、認證可生物降解的生物塑料、塗料、彈性體、路面標記和汽車組件。Ingevity 總部位於南卡羅來納州北查爾斯頓，在全球 24 個地點運營，僱傭約 1500 名員工。公司的普通股在紐約證券交易所（NYSE:NGVT）交易。欲瞭解更多信息，請訪問 ingevity.com。</p>
<p><strong>前瞻性聲明：</strong></p>
<p>本新聞稿包含根據 1934 年證券交易法（經修訂）和 1995 年私人證券訴訟改革法的定義的 “前瞻性聲明”。此類聲明通常包括 “將”、“計劃”、“打算”、“目標”、“期望”、“展望”、“相信”、“預期” 或類似的表達。前瞻性聲明可能包括但不限於領導層變動；預期的財務狀況、指導、經營結果和現金流；融資計劃；以及商業策略和預期。實際結果可能與所表達的觀點存在重大差異。導致實際結果與前瞻性聲明中所包含的內容存在重大差異的因素，或可能導致其他前瞻性聲明被證明不正確的因素，包括但不限於我們最近的 10-K 表格年度報告中第 I 部分第 1A 項 “風險因素” 中詳細列出的因素，以及我們向 SEC 提交的其他文件。這些前瞻性聲明僅反映管理層在本新聞稿發佈日期的信念。Ingevity 不承擔提供任何修訂或更新本新聞稿中包含的任何預測和前瞻性聲明的義務。</p>
<p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTEyMDgxNDQzNTlyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTEyMDgxNDQzNTlyMQ"/></p>
<p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20251208144359/en/</p>
<p>Caroline Monahan</p>
<p>843-740-2068</p>
<p>caroline.monahan@ingevity.com</p>
<p>投資者：</p>
<p>John E. Nypaver, Jr.</p>
<p>843-740-2002</p>
<p>investors@ingevity.com</p>
<p>來源：Ingevity Corporation</p>

NGVT

<p>Ingevity 公司宣佈了關鍵的領導層變動，作為其戰略投資組合審查的一部分。首席財務官 Mary Dean Hall 將在 2026 年 5 月卸任，由 Phillip J. Platt 接任。績效化學品部門總裁 Rich White 將在 2026 年 5 月前轉任特殊項目角色。Reid Clontz 被任命為運營高級副總裁，任命將於 2025 年 12 月生效。這些變動旨在支持 Ingevity 的長期戰略優先事項和增長</p>

<p>NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation (NYSE: NGVT) today announced pivotal executive leadership changes as it completes its strategic portfolio review and positions the company for the future.</p>
<div class="lb-trans"><p>南卡羅來納州北查爾斯頓 --（商業資訊）--Ingevity Corporation（紐約證券交易所代碼：NGVT）今天宣佈了關鍵的高管領導變動，以完成其戰略投資組合審查併為公司的未來做好準備。</p>
</div><p><strong>Chief financial officer transition</strong></p>
<div class="lb-trans"><p><strong>首席財務官過渡</strong></p>
</div><p>Mary Dean Hall, executive vice president and chief financial officer (CFO), will transition from her current role effective May 1, 2026, and continue to support the company in an advisory capacity for a period of one year. Hall has served as CFO since 2021, playing a critical role in strengthening Ingevity’s financial foundation, enhancing operational discipline and supporting strategic growth initiatives. Under her financial leadership, the company achieved significant margin expansion, improved its capital structure and delivered strong free cash flow performance.</p>
<div class="lb-trans"><p>Mary Dean Hall，執行副總裁兼首席財務官（CFO），將於 2026 年 5 月 1 日起從當前職位過渡，並在接下來的一年內繼續以顧問身份支持公司。自 2021 年以來，Hall 一直擔任 CFO，在加強 Ingevity 的財務基礎、提升運營紀律和支持戰略增長計劃方面發揮了關鍵作用。在她的財務領導下，公司實現了顯著的利潤率擴張，改善了資本結構，並交出了強勁的自由現金流表現。</p>
</div><p>“Mary has been a trusted advisor and a driving force behind our financial strategy,” said Dave Li, president and CEO. “Her deep expertise and steady guidance have been instrumental in positioning Ingevity for long-term success. We are grateful for her leadership and pleased she will continue to support the company during this transition.”</p>
<div class="lb-trans"><p>“Mary 一直是我們財務戰略的可信顧問和推動力，” 首席執行官 Dave Li 表示。“她深厚的專業知識和穩定的指導對 Ingevity 的長期成功至關重要。我們感謝她的領導，並很高興她在這一過渡期間繼續支持公司。”</p>
</div><p>The company has appointed Phillip J. Platt, currently senior vice president, finance and chief accounting officer, as Hall’s successor and member of the executive leadership team, effective May 1, 2026. Since joining Ingevity in 2015, Platt has held key finance leadership roles where he led improvements in financial reporting, drove business process transformation and led implementation of the company’s global enterprise resource planning (ERP) system. His experience overseeing global finance operations and driving technology-enabled process improvements positions him well to guide Ingevity’s financial strategy and support the company’s long-term growth.</p>
<div class="lb-trans"><p>公司已任命 Phillip J. Platt，現任高級副總裁、財務和首席會計官，作為 Hall 的繼任者，併成為執行領導團隊的一員，任職將於 2026 年 5 月 1 日生效。自 2015 年加入 Ingevity 以來，Platt 擔任過多個關鍵財務領導職務，領導財務報告的改進，推動業務流程轉型，並主導公司全球企業資源規劃（ERP）系統的實施。他在全球財務運營的監督和推動技術驅動的流程改進方面的經驗，使他能夠很好地指導 Ingevity 的財務戰略並支持公司的長期增長。</p>
</div><p><strong>Performance Chemicals business president transition</strong></p>
<div class="lb-trans"><p><strong>性能化學品業務總裁過渡</strong></p>
</div><p>Rich White, senior vice president and president, Performance Chemicals, will transition to a special projects role, effective January 1, 2026, and will depart the company on May 1, 2026. White was named president of the Performance Chemicals segment in 2021 and has since led Performance Chemicals through a period of strategic repositioning, including margin improvement initiatives, product mix optimization and operational streamlining.</p>
<div class="lb-trans"><p>Rich White，高級副總裁兼性能化學品總裁，將於 2026 年 1 月 1 日起過渡到特別項目角色，並於 2026 年 5 月 1 日離開公司。White 於 2021 年被任命為性能化學品部門的總裁，自那時以來，他領導性能化學品經歷了戰略重組的階段，包括利潤率改善計劃、產品組合優化和運營精簡。</p>
</div><p>“We appreciate Rich’s leadership and contributions to Ingevity,” said Li. “Over the past several years, he has guided the business through complex market conditions and led efforts to restructure the segment portfolio in alignment with our strategic priorities. As he transitions from his current role, we are grateful for his guidance and know his expertise will help ensure continuity and stability.”</p>
<div class="lb-trans"><p>“我們感謝 Rich 對 Ingevity 的領導和貢獻，” Li 表示。“在過去的幾年中，他引導業務應對複雜的市場環境，並領導努力重組部門投資組合，以符合我們的戰略優先事項。在他從當前角色過渡時，我們對他的指導表示感激，並相信他的專業知識將有助於確保連續性和穩定性。”</p>
</div><p><strong>New senior vice president of operations appointment</strong></p>
<div class="lb-trans"><p><strong>新任高級副總裁的任命</strong></p>
</div><p>Ingevity also announced the appointment of Reid Clontz to the role of senior vice president, operations and member of Ingevity’s executive leadership team, effective December 8, 2025. Clontz most recently served as vice president, global operations at Ingevity and brings more than two decades of chemical industry experience to his role, leading operations across multiple manufacturing sites, improving process efficiency and aligning production with sustainability goals. His leadership has been instrumental in optimizing plant operations and driving continuous improvement across the company’s global locations. In his new role, Clontz also assumes leadership for the company’s supply chain, procurement and safety functions.</p>
<div class="lb-trans"><p>Ingevity 還宣佈任命 Reid Clontz 為高級副總裁、運營及 Ingevity 執行領導團隊成員，任職將於 2025 年 12 月 8 日生效。Clontz 最近擔任 Ingevity 的全球運營副總裁，擁有超過二十年的化工行業經驗，領導多個製造基地的運營，提高流程效率，並將生產與可持續發展目標對齊。他的領導在優化工廠運營和推動公司全球各地的持續改進方面發揮了重要作用。在新角色中，Clontz 還將負責公司的供應鏈、採購和安全職能。</p>
</div><p>“These leadership transitions reflect our commitment to evolving our organization to support long-term strategic priorities,” said Li. “We thank Mary and Rich for their significant contributions and are excited to welcome Reid and Phil into their new roles, confident that their deep operational and strategic expertise will help position Ingevity for continued growth and success.”</p>
<div class="lb-trans"><p>“這些領導層的變動反映了我們致力於發展組織以支持長期戰略優先事項，” Li 表示。“我們感謝 Mary 和 Rich 的重大貢獻，並對 Reid 和 Phil 的新角色表示歡迎，確信他們深厚的運營和戰略專業知識將幫助 Ingevity 繼續實現增長和成功。”</p>
</div><p><strong>Ingevity: Purify, Protect, Enhance</strong></p>
<div class="lb-trans"><p><strong>Ingevity：淨化、保護、提升</strong></p>
</div><p>Ingevity provides products and technologies that purify, protect and enhance the world around us. Through a team of talented and experienced people, we develop, manufacture and bring to market solutions that help customers solve complex problems and make the world more sustainable. We operate in three reporting segments: Performance Materials, which includes activated carbon; Advanced Polymer Technologies, which includes caprolactone polymers; and Performance Chemicals, which includes specialty chemicals and pavement technologies. Our products are used in a variety of demanding applications, including adhesives, agrochemicals, asphalt paving, certified biodegradable bioplastics, coatings, elastomers, pavement markings and automotive components. Headquartered in North Charleston, South Carolina, Ingevity operates from 24 locations around the world and employs approximately 1,500 people. The company’s common stock is traded on the New York Stock Exchange (NYSE:NGVT). For more information, visit ingevity.com.</p>
<div class="lb-trans"><p>Ingevity 提供淨化、保護和提升我們周圍世界的產品和技術。通過一支才華橫溢且經驗豐富的團隊，我們開發、製造並推向市場的解決方案，幫助客户解決複雜問題，使世界更加可持續。我們在三個報告部門運營：性能材料，包括活性炭；先進聚合物技術，包括己內酰胺聚合物；以及性能化學品，包括特種化學品和鋪路技術。我們的產品用於多種苛刻應用，包括粘合劑、農用化學品、瀝青鋪路、認證可生物降解的生物塑料、塗料、彈性體、路面標記和汽車組件。Ingevity 總部位於南卡羅來納州北查爾斯頓，在全球 24 個地點運營，僱傭約 1500 名員工。公司的普通股在紐約證券交易所（NYSE:NGVT）交易。欲瞭解更多信息，請訪問 ingevity.com。</p>
</div><p><strong>Forward Looking Statement:</strong></p>
<div class="lb-trans"><p><strong>前瞻性聲明：</strong></p>
</div><p>This press release contains “forward-looking statements” within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words “will,” “plans,” “intends,” “targets,” “expects,” “outlook,” “believes,” “anticipates” or similar expressions. Forward-looking statements may include, without limitation, leadership transitions; expected financial positions, guidance, results of operations and cash flows; financing plans; and business strategies and expectations. Actual results could differ materially from the views expressed. Factors that could cause actual results to materially differ from those contained in the forward-looking statements, or that could cause other forward-looking statements to prove incorrect, include, without limitation, such factors detailed from time to time in Part I, Item 1A. Risk Factors in our most recent Annual Report on Form 10-K as well as in our other filings with the SEC. These forward-looking statements speak only to management’s beliefs as of the date of this press release. Ingevity assumes no obligation to provide any revisions to, or update, any projections and forward-looking statements contained in this press release.</p>
<div class="lb-trans"><p>本新聞稿包含根據 1934 年證券交易法（經修訂）和 1995 年私人證券訴訟改革法的定義的 “前瞻性聲明”。此類聲明通常包括 “將”、“計劃”、“打算”、“目標”、“期望”、“展望”、“相信”、“預期” 或類似的表達。前瞻性聲明可能包括但不限於領導層變動；預期的財務狀況、指導、經營結果和現金流；融資計劃；以及商業策略和預期。實際結果可能與所表達的觀點存在重大差異。導致實際結果與前瞻性聲明中所包含的內容存在重大差異的因素，或可能導致其他前瞻性聲明被證明不正確的因素，包括但不限於我們最近的 10-K 表格年度報告中第 I 部分第 1A 項 “風險因素” 中詳細列出的因素，以及我們向 SEC 提交的其他文件。這些前瞻性聲明僅反映管理層在本新聞稿發佈日期的信念。Ingevity 不承擔提供任何修訂或更新本新聞稿中包含的任何預測和前瞻性聲明的義務。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTEyMDgxNDQzNTlyMQ" alt="" original-src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20251208144359r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"/></p>
<p>View source version on businesswire.com: https://www.businesswire.com/news/home/20251208144359/en/</p>
<div class="lb-trans"><p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20251208144359/en/</p>
</div><p>Caroline Monahan</p>
<div class="lb-trans"><p>Caroline Monahan</p>
</div><p>843-740-2068</p>
<div class="lb-trans"><p>843-740-2068</p>
</div><p>caroline.monahan@ingevity.com</p>
<div class="lb-trans"><p>caroline.monahan@ingevity.com</p>
</div><p>Investors:</p>
<div class="lb-trans"><p>投資者：</p>
</div><p>John E. Nypaver, Jr.</p>
<div class="lb-trans"><p>John E. Nypaver, Jr.</p>
</div><p>843-740-2002</p>
<div class="lb-trans"><p>843-740-2002</p>
</div><p>investors@ingevity.com</p>
<div class="lb-trans"><p>investors@ingevity.com</p>
</div><p>Source: Ingevity Corporation</p>
<div class="lb-trans"><p>來源：Ingevity Corporation</p>
</div>

Ingevity 宣佈重要的領導層變動 | NGVT 股票新聞